Related Experiment Video
Updated: Jul 12, 2026

Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer
Published on: April 26, 2018
Cloning of habutobin cDNA and antithrombotic activity of recombinant protein
Masanori Sunagawa1, Mariko Nakamura, Tadayoshi Kosugi
11st Department of Physiology, Unit of Physiological Science, School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan. sunagam@med.u-ryukyu.ac.jp
Insights
Researchers cloned habutobin cDNA from habu snake venom. Recombinant habutobin from a baculoviral system effectively modulated blood clotting and platelet aggregation, showing potential for antithrombotic drug development.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Habutobin is a protein found in Trimeresurus flavoviridis (habu snake) venom.
- Understanding its structure-function relationship is crucial for potential therapeutic applications.
Purpose of the Study:
- To clone and express habutobin.
- To investigate the functional properties of recombinant habutobin, particularly its effects on blood coagulation and platelet aggregation.
- To assess the utility of different expression systems for producing functional habutobin.
Main Methods:
- Cloning of habutobin cDNA from Trimeresurus flavoviridis.
- Expression of recombinant habutobin using bacterial (pET-r-habutobin) and baculoviral (AcNPV-r-habutobin) systems.
- Purification and refolding of recombinant proteins.
- Assays for fibrin forming activity and collagen-induced platelet aggregation.
Main Results:
- Habutobin cDNA was successfully cloned and translated into a 236-amino acid protein (25.7 kDa).
- Recombinant habutobin was produced and purified via bacterial and baculoviral systems.
- AcNPV-r-habutobin dose-dependently enhanced fibrin formation and inhibited platelet aggregation.
- Refolded pET-r-habutobin showed multiple bands, suggesting potential protein processing.
Conclusions:
- The baculoviral expression system is highly effective for producing functional recombinant habutobin.
- AcNPV-r-habutobin exhibits significant procoagulant and antiplatelet activities.
- Further studies on the structure-function relationship of habutobin are warranted for developing novel antithrombotic drugs.
Abstract:
The habutobin cDNA was cloned from total RNA extracted from venom glands of Trimeresurus flavoviridis (the habu snake). The conceptual translation of 1539 bp of habutobin cDNA consists of 236 amino acids and its molecular weight is 25.7 kDa. Histidine (His)-tagged recombinant habutobin fusion protein, pET-r-habutobin and AcNPV-r-habutobin, was purified by bacterial system and baculoviral system, respectively. After refolding pET-r-habutobin, there were two protein bands at about 32 kDa and 65 kDa, indicating that habutobin might be produced as a monomer protein and processed to form two concatenated protein. Purified AcNPV-r-habutobin dose-dependently increased fibrin forming activity and inhibited collagen-induced aggregation of rabbit washed platelets. Thus, AcNPV-r-habutobin produced by baculoviral system is very useful for study on structure-function relationship, which is necessary for developing an antithrombotic drug from habutobin.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Recombinant DNA

